DENVER, CO and AUCKLAND, NZ (April 21, 2009) – MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback